Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
4.450
+0.120 (2.77%)
At close: Jan 16, 2026, 4:00 PM EST
4.340
-0.110 (-2.47%)
After-hours: Jan 16, 2026, 7:52 PM EST
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $192.57 million as of January 16, 2026. Its market cap has increased by 1,142.39% in one year.
Market Cap
192.57M
Enterprise Value
240.28M
1-Year Change
1,142.39%
Ranking
Category
Stock Price
$4.45
Market Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has increased from $110.60M to $192.57M, an increase of 74.11%. That is a compound annual growth rate of 4.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 31.10M | 10.68% |
| Dec 31, 2025 | 28.10M | 81.29% |
| Dec 31, 2024 | 15.50M | -63.95% |
| Dec 29, 2023 | 43.00M | 405.88% |
| Dec 30, 2022 | 8.50M | -75.15% |
| Dec 31, 2021 | 34.20M | -65.77% |
| Dec 31, 2020 | 99.90M | -64.00% |
| Dec 31, 2019 | 277.50M | 5.92% |
| Dec 31, 2018 | 262.00M | 11.92% |
| Dec 29, 2017 | 234.10M | -42.76% |
| Dec 30, 2016 | 409.00M | 172.49% |
| Dec 31, 2015 | 150.10M | 35.23% |
| Dec 31, 2014 | 111.00M | 0.36% |
| Jul 1, 2014 | 110.60M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |